Xiaonan Xi

Tianjin, 300387, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Targeting cystathionine-β-synthase (CBS)-mediated cell stemness and gut microbiome homeostasis: mechanism and clinical study of combined resveratrol-curcumin treatment for ulcerative colitis.

Targeting cystathionine-β-synthase (CBS)-mediated cell stemness and gut microbiome homeostasis: mechanism and clinical study of combined resveratrol-curcumin treatment for ulcerative colitis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 30, 2026

Targeting the MDK/c-Myc complex to overcome temozolomide resistance in glioma.

Targeting the MDK/c-Myc complex to overcome temozolomide resistance in glioma.

Journal: Clinical and translational medicine

Published: December 31, 2024

Structure-Activity Relationship Study of Majusculamide D: Overcoming Metabolic Instability and Severe Toxicity with a Fluoro Analogue.

Structure-Activity Relationship Study of Majusculamide D: Overcoming Metabolic Instability and Severe Toxicity with a Fluoro Analogue.

Journal: Marine drugs

Published: October 15, 2024

Anti-angiogenesis in colorectal cancer therapy.

Anti-angiogenesis in colorectal cancer therapy.

Journal: Cancer science

Published: September 18, 2023

Corrigendum: Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2.

Corrigendum: Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2.

Journal: Angewandte Chemie (International ed. in English)

Published: September 19, 2022

Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2.

Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2.

Journal: Angewandte Chemie (International ed. in English)

Published: May 12, 2022

Phellodendrine promotes autophagy by regulating the AMPK/mTOR pathway and treats ulcerative colitis.

Phellodendrine promotes autophagy by regulating the AMPK/mTOR pathway and treats ulcerative colitis.

Journal: Journal of cellular and molecular medicine

Published: January 19, 2021

Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.

Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.

Journal: Theranostics

Published: February 01, 2020

ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma.

ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma.

Journal: Cell death & disease

Published: June 03, 2019

Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.

Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.

Journal: Journal of translational medicine

Published: November 12, 2018

Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.

Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.

Journal: Journal of medicinal chemistry

Published: July 31, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026